Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.

Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.

Item
http://www.wikidata.org/entity/Q39132041
New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Brentuximab vedotin related bilateral Purtscher-like retinopathy unresponsive to pulse steroid therapy and intravitreal aflibercept injection.Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma.Monoclonal antibodies against cutaneous T-cell lymphomas.Cancer: Towards a general theory of the target: All successful cancer therapies, actual or potential, are reducible to either (or both) of two fundamental strategies.CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era.
P2860

Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.

Item
http://www.wikidata.org/entity/Q39132041
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.
@en
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.
@nl
type
label
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.
@en
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.
@nl
prefLabel
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.
@en
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.
@nl
P1433
P1476
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.
@en
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698